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Epithelial ovarian carcinoma is thought to derive from ovarian surface epithelium (OSE). The black box of the early molecular changes
in ovarian carcinogenesis is being interpreted by the development of experimental systems employing immortalised human OSE cells.
However, the existing cell lines of the OSE cells have limited utility due to chromosomal instability. Our goal was to establish new
immortalised human OSE cells that retain the original characteristics of the primary cells without chromosomal alterations. Using
primary human OSE cells obtained from a postmenopausal patient with endometrial cancer, five cell lines (‘HOSE1’ lines) were newly
established by infection with retroviral expression vectors containing type 16 human papillomavirus (HPV-16) E6, E7, a variant E6
(E6D151), and Bmi1 polycomb gene, in combination with telomerase reverse transcriptase (hTERT). Consequently, five HOSE1s cell
lines, HOSE1s-E6/hTERT, -E7/hTERT, -E6/E7/hTERT, -E6D151/E7/hTERT, and -E6D151/Bmi1/hTERT, grew beyond the population
doubling number of 200. These cell lines, except for HOSE1-E6/hTERT, essentially showed the original features of the primary human
OSE cells. Of them, HOSE1-E7/hTERT preserved diploidy in a kariotype analysis, and did not show transformed phenotypes in
anchorage-independent growth and tumour formation. Thus, HOSE1-E7/hTERT may provide a novel model system with which to
investigate the mechanisms of early molecular changes.
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Most epithelial ovarian carcinomas are considered to arise from
ovarian surface epithelium (OSE), a single continuous layer of
flat-to-cuboidal mesothelial cells covering the ovary (Okamura
and Katabuchi, 2005). In epithelial ovarian carcinoma, numerous
studies have revealed different patterns of genetic change. These
include activation of oncogenes (K-ras, HER-2, Src, c-myc, AKT2,
PIK3CA and STK/BTAK) through amplification, translocation, or
mutation (Slamon et al, 1989; Enomoto et al, 1991; Tashiro et al,
1992; Bellacosa et al, 1995; Zhou et al, 1998; Shayesteh et al, 1999;
Wiener et al, 2003), as well as inactivation of tumour suppressor
genes (p53, PTEN, WT1, BRCA 1, NOEY2 and WWOX) through
homozygous deletion, double mutations, or a combination of
mutation and loss of heterozygosity or promotor methylation
(Fujita et al, 1995; Obata et al, 1998; Yu et al, 1999; Schorge et al,
2000; Paige et al, 2001; McCoy et al, 2003). Although such genetic
changes have long been identified using ovarian carcinoma tissues
or cell lines, the early molecular changes in ovarian carcinogenesis
have not been fully clarified. In addition, adequate experimental
systems and suitable animal models are lacking due to sponta-
neous epithelial ovarian tumours being extremely rare in
nonprimate mammals, including mice. During the last decade,
the isolation, culture, and immortalisation of human OSE cells was
developed (Maines-Bandiera et al, 1992; Tsao et al, 1995; Nitta
et al, 2001). Using the experimental system of Auersperg et al
(1999), E-cadherin expression was recently addressed in human
ovarian carcinogenesis (Ong et al, 2000). Furthermore, in the OSE
cells, autocrine HGF-Met and LH-LH/hCG receptor loops have
been shown to be involved in early carcinogenesis (Wong et al,
2001; Tashiro et al, 2003). Although the system using the
immortalised human OSE cell lines would serve as relevant
models, the utility of the existing cell lines is limited by their
accumulation of chromosomal instability. The establishment of new
cell lines without such genetic instability is required to advance
further research of carcinogenesis.
The proliferation potential of epithelial cells is determined by
three independent stages: mortality stage 0 (M0) Foster et al
reported (Foster and Galloway, 1996; Foster et al, 1998), mortality
stage 1 (M1) and mortality stage 2 (M2), Shay et al described (Shay
et al, 1991; Wright and Shay, 1992). Epithelial cells appear to
senesce in initial growth arrest, M0, which is controlled by the p16/
Rb pathway. Following progressive shortening of telomere length
in cell divisions, the next growth arrest, M1, is induced by telomere
shortening and activation of p53/p21 pathway. When the p16/Rb
and p53 functions are inactivated, the cells overcome M0 and M1.
However, even after epithelial cells have bypassed these stages,
telomere shortening continues until the cells reach a crisis, M2,
which is characterized by marked chromosomal instability and
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schromosome fusion (Zakian, 1989; Blackburn, 1991). Most of cells
die in the crisis, but the remaining small number of cells acquires
telomerase activity and prevents the crisis.
Primary human OSE cells have limited proliferative potential
and fall into early senescence within 2-8 passages in vitro. Until
now, using human OSE cells, two kinds of immortalised cell lines
were established by introduction of SV40 large T antigen (LT)
(Maines-Bandiera et al, 1992; Nitta et al, 2001) or by human
papillomavirus (HPV) E6 and E7 (E6/E7) transduction (Tsao et al,
1995). The OSE cells transduced by SV40 LT and by E6/E7 had
chromosomal alterations ranging in number from 50 to 69 (Nitta
et al, 2001) and 43 to 88 (Tsao et al, 1995), respectively. These
OSE cells were not thought to have active telomerase, and conse-
quently resulted in chromosomal alterations. Hence, we postulated
that inhibition of p16/Rb and/or p53 pathways in combination
with activation of telomerase may induce immortalisation, while
abolishing chromosomal instability. Our goal was to establish
immortalised human OSE cell lines without chromosomal instabi-
lity, by transducing E6 or a variant E6 with a mutation of PDZ
domain-binding site for the inhibition of p53, E7 for the inhibition
of RB, and polycomb family transcriptional repressor Bmi1 for
inhibition of p16 (Jacobs et al, 1999), in combination with human
telomerase reverse transcriptase (hTERT) for the activation of
telomerase.
MATERIALS AND METHODS
Isolation of human OSE and primary cell culture
Both ovaries were obtained from a postmenopausal patient
undergoing abdominal total hysterectomy and bilateral salpingo-
oophorectomy for endometrial cancer (International Federation of
Gynecology and Obstetrics: stage IIIc, TMN classification:
pT1bN1M0, peritoneal washing smear: negative) at Kumamoto
University Hospital, Japan. The Ethics Committee of Kumamoto
University approved this study and the subject gave her informed
consent for participation. The ovaries were grossly normal and no
pathological lesions were observed by subsequent histological
examination. After collagenase digestion under aseptic conditions,
the OSE cells were scraped with a surgical blade as described
previously (Nakamura et al, 1994). The viability of these cells was
more than 95%, as shown by the trypan blue dye exclusion test.
Subcultured OSE cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM)/F12 (1:1 mixture) (Invitrogen, NY, USA) supple-
mented with 10% fetal bovine serum (FBS; Thermo Trace Ltd,
Melbourne, Australia), 100Uml
 1 penicillin G (P), and 100mgml
 1
streptomycin (S) in a humidified 5% CO2 incubator at 371C. Upon
reaching confluency, cells were detached from the dish with 0.125%
trypsin and 0.11% ethylenediamine tetraacetic acid (EDTA) and split
in a 1:2 ratio in a new culture dish.
Vector construction and retroviral transduction of E6,
variant E6, E7, or Bmi1 as well as hTERT
pCMSCVpuro comprises the CMV/LTR fusion promotor, the
packaging signal Psiþ, and the multicloning sequence from
pCLXSN (Imgenex Corp.,. San Diego, CA, USA) followed by the
PGK-puro cassette and the 30 long terminal repeat of murine
embryonic stem cell virus from pMSCVpuro (Clontech, Palo Alto,
CA, USA). The Gateway system (Invitrogen, Carlsbad, CA, USA)
was used for subcloning genes into retroviral vectors. The
destination vectors, pCLXSN-DEST and pDEST-CMSCVpuro, were
constructed by inserting a modified cassette containing attR sites
and ccdB (Invitrogen) between the XhoI and BamHI sites of
pCLXSN, and between the EcoRI and BglII sites of pCMSCVpuro,
respectively. Cloning of the full-length hTERT cDNA and human
Bmi-1 cDNA has been described previously (Okamoto et al, 2002).
After cloning segments of HPV16 E6 (16E6), E7 (16E7), and a
deletion mutant of HPV E6, 16E6SD-d151 (E6D151) (Kiyono et al,
1997), these segments were recombined into the retroviral vectors
by the LR reaction (Invitrogen) to generate pCMSCVpuro-hTERT,
pCLXSN-16E6, pCLXSN-16E6D151, and pCLXSN-16E7. pCLXSN-
16E6E7 was constructed by inserting an EcoRI-BamHI segment
containing HPV16 E6 and E7 between the EcoRI and BglII sites
of pCLXSN. Production of recombinant retroviruses was as
previously described (Naviaux et al, 1996). Briefly, retroviral
vector and packaging construct, pCL-10A1, were cotransduced
into 293T cells using TransIT-293 (Mirus Co., Madison, WI, USA)
according to the manufacturer’s instructions. The culture fluid was
harvested at 48 to 72h post-transduction. The titer of the recombi-
nant viruses was greater than 1 10
5 drug-resistant colony-
forming unitsml
 1 on Hela cells. A 1ml aliquot of the culture
fluid in the presence of polybrene (4mgml
 1) was added in 24-well
dishes on which the cells were seeded. Following inoculation with
viruses, cells were grown without drug selection as mock-infected
cells stopped growing within 2 weeks. To achieve combinations
of retroviral infections, cells were infected with LXSN-16E6, LXSN-
16E7, LXSN-16E6E7, LXSN-hBmi1, or LXSN alone, at passage 2,
and subsequently reinfected with MSCV-hTERT at passage 3.
Alternatively, the cells infected with either LXSN-16E7 or
LXSN-hBmi1 and MSCV-hTERT were additionally infected with
LXSN -16E6D151 at passage 5.
Cell culture
The transduced OSE cells were maintained in DMEM/F12 (1:1)
supplemented with 10% FBS, 100Uml
 1 penicillin G, and
100mgml
 1 streptomycin in an atmosphere of 5% CO2 at 371C.
When confluent, transduced cells were trypsinised and subcul-
tured in a split ratio of 1:4–16. Cells were defined to be
immortalised when the population doubling level of the trans-
duced cells surpassed 100 population doubling levels (Kyo et al,
2003). Cells were seeded into 24-well plates and each well counted
daily. Growth curves were constructed, and doubling times were
estimated. The human ovarian cancer cell line, NIH;OVCAR-3
(OVCAR-3), was obtained from Cell Resource Center for
Biomedical Research, Tohoku University, Japan, and cultured
under the same conditions as the HOSE1s cells.
TRAP assay
In each of the cell lines, telomerase activity was examined by
the telomeric repeat amplification protocol (TRAP) assay using
the TRAPeze kit (Intergen, Burlington, MA, USA) according to the
manufacturer’s instructions.
Western blotting
A2 0 mg protein sample from whole-cell extracts was separated by
SDS–PAGE and blots were prepared on Immobilon-P membrane
(Millipore, Billerica, MA, USA). The following antibodies were used
as probes: for p53 and p21 proteins, clones DO-1 and EA-10,
respectively (Oncogene Science, Cambridge, MA, USA); for Rb and
p16 proteins, clones G3-245 and G175-405, respectively (PharMingen,
San Diego, CA, USA); for Bmi1 protein (produced by Kiyono et al,
unpublished). Blots were then probed with horseradish-peroxidase-
conjugated goat anti-mouse IgG (Jackson Immuno Research, West
Grove, PA, USA) and visualised using the chemiluminescence system
(Amersham, Biosciences, Piscataway, USA).
Reverse transcriptase–polymerase chain reaction
(RT–PCR)
Total RNA was prepared from the cultured cells using Trizol
reagent, as described by the manufacturer. cDNA was synthesised
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sfrom 5mg of total RNA using Oligo dT12 18 Primers (Invitrogen,
CA, USA) as the primer and Superscript II Rnase HReverse
Transcriptase (Invitrogen). Amplification of E-cadherin was
performed for 30 cycles (denaturation for 30s at 941C, annealing
for 40s at 571C and extension for 30s at 721C) in a standard 50ml
PCR mixture. The reaction mixture contained 1ml cDNA from the
RT reaction, 0.2mM of the first pair of upstream and downstream
primers, 5ml1 0   PCR buffer (Invitrogen), 0.2mM dNTP
(Invitrogen), 1.5mM MgCl2 (Invitrogen), and 5U Taq DNA
polymerase (Invitrogen). The sequences of the RT–PCR primers
were 50-GAGGAGAGCGGTGGTCAAAG-30 (sense) and 50-
GTTCAGGGAGCTCAGACTAG-30 (antisense) for E-cadherin to
produce a 351bp PCR product (Nishida et al, 2003). The primer
sequences for human glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) as internal control were 50-GAA GGT GAA GGT CGG
AGT-30 (sense) and 50-GAA GAT GGT GAT GGG ATT TC-30
(antisense) to produce a 226bp PCR product. Polymerase chain
reaction was carried out in a Thermal Cycler (PC 701; Astec,
Fukuoka, Japan). The amplified PCR products were analysed by
electrophoresis through 2.0% agarose gel, visualised by ethidium
bromide staining, and photographed under ultraviolet illumina-
tion. The 100bp DNA ladder (BioLabs, Beverly, MA, USA) was
used for determining the molecular size of amplified products.
OVCAR-3 was employed as a positive control. As a negative
control, distilled water was used in place of cDNA in all the
reactions.
Immunocytochemistry
HOSE1s cells were cultured on Lab Tech Chamber slides (Nalge
Nunc International, Rochester, NY, USA) for 24h. They were fixed
in 95% ethanol for 10min at room temperature and washed with
PBS. Endogenous peroxidase activity was blocked with 0.03%
hydrogen peroxide in methanol for 5min. The cultured chamber
slides were stained with the following mouse monoclonal
antibodies: pan-cytokeratine (1:50 dilution, DAKO, Carpinterio,
CA, USA), vimentin (1:10 dilution, DAKO), epithelial membrane
antigen (EMA) antibody (1:200 dilution, DAKO), CA125 (1:100
dilution, DAKO), or collagen IV (1:100 dilution, Sigma-Aldrich, St
Louis, MO, USA) for 30min at room temperature. Staining
reactions were performed using the indirect method using an
ENVISIONþ (DAKO). Peroxidase activity was visualised with
3,30-diaminobenzidine (Sigma-Aldrich) as a substrate in Tris-HCl
buffer (0.5mgml
 1 pH 7.6) containing 0.01% H2O2. Nuclear
staining was performed with Mayer’s haematoxylin.
CA125 levels in culture medium
Medium was changed every 2 days and was taken from cultures
with a cell density varying between 0.6–1.7 10
6 cellsml
 1
growing in 6cm dishes. The CA125 in the supernatant was
measured by electrochemiluminescence immunoassay using
Elecsys CA 125 (Roche Diagnostics K.K., Tokyo, Japan).
Karyotype analysis
Karyotype analyses were performed at passage 16 and passage
41 for each cell line. Routine karyotypic analysis was performed
using preparations stained with 5% Giemsa solution. In order to
identify possible rearrangements, chromosomes of metaphases
were G-banded. For each cell line, more than 50 cells were scored
for their chromosome number. Chromosomal analysis of the most
stable line at passage 41 was added at 60 passage.
Cell proliferation assay (anchorage-dependent growth)
HOSE1s cells were placed in separate 96-well microtitre plates at
a density of 2 10
3 cells well
 1 and allowed to grow for 24h in
DMEM with 10% FBS. The Biotrak Cell Proliferation ELISA System
Version 2 (Amersham Pharmacia Biotech, Uppsala, Sweden) was
used for the cell proliferation assay. Briefly, cells were incubated in
5-bromo-20-deoxyuridine (BrdU) labelling solution. Following cell
fixation and DNA denaturation, specimens were incubated in
peroxidase-labelled anti-BdrU. Subsequently, 3,30,5,50-tetramethyl-
benzidine was added as a substrate to detect immune complexes.
Absorbance was calculated from the absorbance at 450nm
measured using a microtitre plate reader.
Assay for colony formation in soft agar (anchorage-
independent growth)
Colony formation in semisolid agar was assayed by suspending
4 10
3 cells in 2ml of DMEM/F12/10% FBS with 0.33% agarose
(Sigma-Aldrich) and placing this suspension on top of 2ml of
solidified 0.5% agarose in the above medium. Six cultures for each
cell type were maintained for 21 days at 371C in a 5% CO2
atmosphere with fresh medium changed every 1 week. Colonies
larger than 100mm in diameter were counted after a lapse of 3
weeks. The experiments were repeated three times.
Assay for tumour formation in athymic nu/nu mice
Female athymic BALB/cA nu/nu mice, aged 4 weeks and weighting
15–18g, were obtained from CLEA Japan (Tokyo, Japan). Mice
were maintained in a clean box at 22721C and 50–70% humidity
on a 12h light–dark cycle. Gamma-ray-irradiated solid food was
provided by Oriental Yeast (Tokyo, Japan), and drinking water was
acidified with HCl to a pH of 2.5–3.0. All procedures in this assay
were approved by the Center for Animal Resources and Develop-
ment of Graduate School of Medical Science, Kumamoto
University.
Cells of E7/hTERT and OVCAR-3 were harvested with trypsin:
EDTA, and the pellet of cells obtained by centrifugation was
suspended in growth medium (3.6 10
7 cellsml
 1). Aliquots
(0.1ml) were injected subcutaneously into the subscapular areas
of athymic BALB/c nu/nu mice and observed for tumorigenic
growth every week for a 4-month period.
Statistical analysis
The Mann–Whiteney U-test was used to assess the differences in
the proliferation assay. Differences were considered to be
significant at Po0.05. This analysis was made using the StatView
system (Abacus, Berkeley, CA, USA).
RESULTS
Telomerase and cell cycle regulator in primary human OSE
and transduced cells
All transduced cells showed telomerase activity in a TRAP assay
at passage 7 (data not shown). In primary human OSE cells,
p16 protein levels were quite high as early as passage 4, and
levels of p53 and p21 proteins increased through passage 4–6
(Figure 1). Expression of p53 and p21 proteins in all seven trans-
duced HOSE1 cell groups were inhibited by harbouring E6 or
E6D151 (HOSE1s-E6/hTERT, -E6/E7/hTERT, -E6D151/E7/hTERT,
and -E6D151/Bmi1/hTERT), while they were increased by E7 alone
(HOSE1-E7/hTERT) when compared with those of primary cells
(Figure 1). It could be supported by the fact that blockage of Rb
pathway enhances p53 pathway via induction of p14ARF (Bates
et al, 1998). The expression of p16 protein was slightly suppressed
by Bmi1 alone (HOSE1-Bmi1/hTERT), and was elevated in cells
expressing E7 (HOSE1s-E7/hTERT, -E6/E7/hTERT and -E6D151/
E7/hTERT), as E7 allowed high p16 levels through inactivation of
Rb (Figure 1). Our data were consistent with previous studies that
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highly expressed p53, p21, and p16 (Foster and Galloway, 1996;
Kiyono et al, 1998; Jarrard et al, 1999; Mori et al, 2005).
Long-term culture and immortalisation by transduction
The two cell lines HOSE1s-hTERT and -Bmi1/hTERT fell into
senescence within passages 8–10, whereas the cells of
HOSE1s-E6/hTERT, -E7/hTERT, -E6/E7/hTERT, -E6D151/E7/hTERT,
and -E6D151/Bmi1/hTERT grew beyond a population doubling
number of 100. Consequently, they were defined as immortalised
cell lines. Moreover, these five cell lines are now growing with
a population doubling number greater than 200. The doubling time
(DT) of the HOSE1s cells was 23.4–36.9h (Table 1). Furthermore,
in the anchorage-dependent proliferation assay, cell proliferation
of HOSE1s cells was significantly higher than that of primary human
OSE cells (Po0.05) (Figure 2). The three cell lines, HOSE1s-E6/E7/
hTERT, -E6D151/E7/hTERT, and -E6D151/Bmi1/hTERT, inhibited
b o t hp 1 6 / R ba n dp 5 3 ,a n ds h o w e ds h o r t e rD Ta n dp o s s e s s e dh i g h e r
proliferative ability than -E6/hTERT and -E7/hTERT cells (Figure 2
and Table 1).
Karyotype analysis
Although HOSE1s-E6/hTERT, -E6/E7/hTERT, -E6D151/E7/hTERT,
and -E6D151/Bmi1/hTERT exhibited almost normal chromosomal
number with small deviation ranging between 42 and 48 in early
passage (passage 16), they did show chromosomal alteration
varying from 43 to 96 after immortalisation (passage 41)
(Table 2A). HOSE1-E7/hTERT alone revealed normal diploidy in
both passages (Figure 3 and Table 2B). In late passage (passage 41),
the G-banded karyotype of this cell line was normal in five of
12 cells, 46, XX, showed minor structural alteration including 46,
XX, t(7;7)(p10;p10) in five of 12 cells, and showed 46, idem,
-X, þi(X)(p10), add(1)(p36), add(10)(p11) in two of 12 cells
(Table 2B). Futhermore, karyotype of the HOSE1-E7/hTERT cells
at passage 60 was additionally analysed. All 50 cells revealed also
diploidy and the G-banded karyotype of this was 46, XX in three of
13 cells and showed a minor structural alteration indicated 46, XX,
t(7;7)(p10;p10) in 10 of 13 cells.
Morphological characterisation
The growth patterns of HOSE1s cells on culture dishes were
morphologically divided into two phenotypes (Figure 4 and
Table 1). One was a ‘flat-epithelial type’ and was defined as a
cobblestone arrangement of cuboidal epithelial-like monolayer
cells, similar to the growth pattern of primary human OSE cells.
The other was a ‘fibroblast-like type’ and was defined as an
atypical or fusiform pattern. The growth patterns of HOSE1s-E7/
hTERT, -E6/E7/hTERT, and -E6D151/E7/hTERT were classified as
‘flat-epithelial type’, while those of immortalised HOSE1s-E6/
hTERT and -E6D151/Bmi1/hTERT were classified as ‘fibroblast-
like type’ (Figure 4).
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Figure 1 Western blot analysis of Bmi1, p16, p53, and p21 proteins in
primary human OSE cells and the immortalised HOSE1s cells. The left
three lanes indicated primary human OSEs cells at passages 4, 6, and 8. The
other seven lanes showed expression in the immortalised HOSE1s cells at
passage 8. LXSN/hTERT was HOSE1 cells transduced with hTERT alone.
Table 1 Phenotype and growth of immortalised HOSE1s cells and ovarian cancer cell line (OVCAR-3)
Morphological
type
Doubling
time (h)
Population
doubling level
Colony efficiency
in soft agar (%)
Tumour formation
in nu/nu mice
E6/hTERT Fibroblastic 36.9 204 0.0870.08 N.E.
E7/hTERT Epithelial 35.1 242 0.0070.00 0/5
E6/E7/hTERT Epithelial 26.1 210 0.0870.10 N.E.
E6D151/E7/hTERT Epithelial 23.4 245 1.5570.36 N.E.
E6D151/Bmi1/hTERT Fibroblastic 29.7 204 0.0270.04 N.E.
OVCAR-3 Epithelial N.E. N.E. 49.0575.22 4/5
N.E.¼not examined.
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Figure 2 Cell proliferation assay of the immortalised HOSE1s cells and
primary OSE cells. Data represented the absorbance of each cell type.
Individual values were compared using Mann–Whitney’s U-test and were
significantly different from primary OSE cells (*; Po0.05).
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sImmunocytochemical characterization for cytoskeleton
component
In immunocytochemistry, HOSE1s cells except for HOSE1-E6/
hTERT expressed cytokeratin, vimentin, and collagen IV, but
did not express EMA, similar to the primary human OSE cells
(Table 3). The cells of HOSE1-E6/hTERT expressed vimentin
and collagen IV, but did not express cytokeratin or EMA
(Table 3).
E-cadherin expression
The expression of E-cadherin in HOSE1s cells and an ovarian
cancer cell line was examined by RT–PCR. The ovarian cancer cell
line, OVCAR-3, expressed the mRNA of E-cadherin, but none of
the HOSE1s cells did, identical to the primary OSE cells (data not
shown).
CA125 secretion
None of the HOSE1s cells expressed CA125 in immunocyto-
chemistry, as with the primary OSE cells, while the ovarian cancer
cell line, OVCAR-3, did (Table 1). Correspondingly, the HOSE1s cells
secreted little CA125 (1.8370.21–2.0370.26IUl
 1) and OVCAR-3
highly produced CA125 (1216.67776.38 IUl
 1) in culture media.
Colony formation and tumour formation in HOSE1s cells
The anchorage-independent growth property of HOSE1s cells
was examined by the colony formation assay in soft agar. The
colony efficiency of HOSE s-E6/hTERT, -E7/hTERT, -E6/E7/
hTERT, -E6D151/E7/hTERT, and -E6D151/Bmi1/hTERT was 0.08,
0.00, 0.08, 1.55, and 0.02%, respectively. Correspondingly, the
efficiency of OVCAR-3 was 49.0575.22% (Table 1).
The cells of HOSE1-E7/hTERT and OVCAR-3 cells were injected
subcutaneously into the subscapular areas of athymic nu/nu mice.
Although tumour formation (41cm) was observed in four of the
five mice injected with OVCAR-3 within 4 months, no tumours
were found in the mice injected with HOSE1-E7/hTERT (Table 1).
DISCUSSION
Telomere loss was previously considered to be the sole factor
governing senescence since transduction of hTERT was sufficient
to immortalize human fibroblasts of mesenchymal cells (Bodnar
et al, 1998). However, other factors were also thought to be
involved in senescence of human epithelial cells because several
kinds of epithelial cells were unable to be immortalised by
telomerase activation alone (Kiyono et al, 1998; Kyo et al, 2003). It
Table 2 Chromosomal analysis of immortalised HOSE1s cells: (A) Chromosomal numbers of immortalised HOSE1s cells; (B) Karyotype analysis of
immortalised HOSE1s cells
(A) Chromosome number
Cell lines Passage 16 Passage 41
E6/hTERT 42–48 43–87
E7/hTERT 46–47 46
E6/E7/hTERT 43–48 43–55
E6D151/E7/hTERT 46–47 84–96
E6D151/Bmi1/hTERT 42–46 58–92
Cell lines (B) Karyotype analysis
E6/hTERT 63–87o3n4,X X , X[10], add(X)(q22)[2], +2[2], +3[3], 4[10], add(4)(q35)[7], +5[9], +6[2], +7[8], +8[10], +8[6], +9[7],
+10[7], +11[9], +12[4], add(12)(q24)[7],  13[9],  14[9],  15[8], +16[9],  17[5], +18[6], add(18)(q21)[5], +19[7],
+19[2],+20[10], +20[9], +20[5], +21[10], +22[7], +22[2], +mar1[2], +mar2[3]
E7/hTERT A
a : 46XX, B
b : 46, XX, t(7;7)(p10;p10) add(10)(p11), C
c : 46, idem,  X, +i(X)(p10), add(1)(p36)
E6/E7/hTERT 43–47, XX, ins(11;?)(q21;?)[2],  13[3], del(13)(q14)[3],  14[3], add(15)(q13)[5], ins(15;?)(q15;?)[2], +20[4], add(22)(p11)[5]
E6D151/E7/hTERT 88–93o4n4, XXXX, del(X)(q2?)[3], i(1)(p10)[8],  2[10],  4[3], +5[7], +6[7],  10[4], add(10)(p11)[5], +12[9],  13[9],  13[3],
 14[3],  15[10], add(15)(p11)[4], add(15)(p11)[3],  19[8], +20[10], +20[7],  22[5], +mar1[10]
E6D151/Bmi1/hTERT 76–82o4n4, XXXX, del(1)(q11)x2[2],  2[9], add(3)(p11)[2],  4[7], +add(5)(p11)[2], i(5)(p10)[2],  7[4],  12[4],
add(12)(p11)[3], del(12)(p11)[2],  13[10],  13[9],  15[9],  16[8],  16[4],  17[8],  17[5],  18[8],  18[3],  19[7],  22[5],
+mar1[2]
The numbers of cells were
a5,
b5, and
c2 of 12 cells.
1
6
13
19 20
Number of
chromosome
21 22 X Y
14 15 16 17 18
78 9 1 0 1 1 1 2
23 4 5
45 46 47
05 0 0 5 0
Total
Cell count
Figure 3 Karyotype of HOSE1-E7/hTERT cells. The chromosomal
number was diploid after long–term culture (passage number 41;
population doubling 142).
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shas been generally assumed that the mortality of epithelial cells is
attributed to three stages (Foster and Galloway, 1996; Foster et al,
1998): M0 for activation of the p16/Rb pathway, M1 for telomere
shortening and activation of the p53/p21 pathway, and M2 for
further shortening of telomeres in cells with inactivated p53/p21
pathway (Shay et al, 1991; Wright and Shay, 1992; Foster and
Galloway, 1996; Foster et al, 1998).
OSE have the same origin as peritoneal mesothelial cells
covering the intraperitoneal organs and have the properties of
both epithelial and mesenchymal cells (Okamura and Katabuchi,
2005). Lately, the lifespan of human OSE cells was reported to be
prolonged by telomerase activation alone, but the OSE cells were
unable to be immortalised similarly to the epithelial cells (Alvero
et al, 2004). Thereby, inhibition of the three stages, alone or in
combination, was added to our experimental design for immorta-
lisation of the mesothelial OSE cells. In particular, we transduced
Bmi1 (Jacobs et al, 1999), E7, and E6 for inhibition of p16, Rb, and
p53, respectively, as well as hTERT for activation of telomerase.
In the study presented here, five cell lines except for two lines of
HOSE1s-Bmi1/hTERT and -hTERT were immortalised and grew
over a population doubling level of 200. Both inhibitors of p16/Rb
and p53 in combination with hTERT highly enhanced cell
proliferation, and induced immortalisation. In addition, either E7
alone for p16/Rb inhibition, or E6 alone for p53 inhibition, in
combination with hTERT, less enhanced it than both inhibitors.
Nevertheless, their combination also successfully immortalised the
OSE cells with slow cell growths.
Cell immortalisation maintaining chromosomal stability was
the primary aim of the present study. After immortalisation,
chromosomal analysis showed diploidy in the HOSE1-E7/hTERT
cell line alone. Chromosomal alteration was revealed in the other
cell lines despite hTERT-transduction to abolish chromosomal
crisis. Interestingly, similar results have been reported for
preadipocytes and bone marrow stromal cells immortalised by
introduction of E7 and hTERT (Darimont et al, 2003; Mori et al,
2005). In these immortalised cells, functional p53 was induced by
E7 probably through upregulation of p14ARF (Bates et al, 1998).
The active p53 could have prevented chromosomally abnormal
cells from emerging and proliferating. Conversely, inactivation of
p53 induces chromosomal alteration by abnormal centrosome
amplification (Fukasawa et al, 1996), and abolishes DNA damage
checkpoint and p53-dependent apoptosis. The other cell lines
immortalised with the help of E6 or E6D151 might have greater
Figure 4 Morphological phenotype of immortalised HOSE1-E6/hTERT, -E7/hTERT, -E6/E7/hTERT, -E6D151/E7/hTERT and -E6D151/Bmi1/hTERT.
Passage number of all HOSE1 cells was 40. The morphological phenotypes of HOSE1-E7/hTERT (B), -E6/E7/hTERT (C) and -E6D151/E7/hTERT (D) were
‘flat-epithelial type’, while those of HOSE1s-E6/hTERT (A) and -E6D151/Bmi1/hTERT (E) were ‘fibroblast-like type’. Scale bar¼100mm.
Table 3 Immunocytochemical profile of immortalised HOSE1s cells
Cytokeratin Vmientin EMA
a Colllagen IV CA125
Primary OSE cells + +   +  
E6/hTERT   +   +  
E7/hTERT + +   +  
E6/E7/hTERT + +   +  
E6D151/E7/hTERT + +   +  
E6D151/Bmi1/hTERT + +   +  
aEMA¼epithelial membrane antigen. +¼positive,  ¼negative.
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schance to accumulate chromosomal changes as a result of
inactivated p53.
OSE have the properties of both epithelial and mesenchymal
cells from the viewpoint of embryonal development, as described
above. Cultured OSE cells have been shown to be highly responsive
to environmental influences, and to exhibit mesenchymal mor-
phology at each passage under standard culture conditions
(Auersperg et al, 1994, 2001), that is, epithelio-mesenchymal
transition (EMT). In the present study, the immortalised HOSE1s
cells grew as flat epithelial cells or fibroblast-like cells. Among
them, HOSE1-E7/hTERT without chromosomal instability showed
flat epithelial phenotype. Immunocytochemically, the immorta-
lised HOSE1s cells have the same cytoskeletal properties as the
primary HOSE1 cells, except for cytokeratin negativity in HOSE1-
E6/hTERT cells. The negativity would account EMT in cultured
condition (Auersperg et al, 1994). However, the possibility of
contamination of the stromal cells by scraping method would not
be denied.
Previously, OSE cells were shown to become more firmly
committed to an epithelial phenotype in the process of malignant
transformation (Maines-Bandiera et al, 1992; Auersperg et al,
1994). Similar to primary human OSE cells, our immortalised
HOSE1 cells did not express E-cadherin or CA125, which were
expressed in the ovarian cancer cell line, OVCAR-3 (van Niekerk
et al, 1989; Auersperg et al, 1999). In addition, to examine whether
the immortalised HOSE1 cells were transformed, they were tested
for anchorage-independent growth in a soft agar and assayed for
tumorigenicity in athymic nu/nu mice. HOSE1-E7/hTERT, with a
normal chromosomal number, did not form any colonies in soft
agar medium or tumours in athymic nu/nu mice. Consequently,
this cell line was concluded not to have major transformed
phenotype.
We have been the first to establish a transduced HOSE1 cell line
(HOSE1-E7/hTERT) that have no major chromosomal alterations
or transformation activity. Immortalised HOSE1-E7/hTERT could
now serve as a relevant model for investigation of the molecular
aetiology of epithelial ovarian carcinomas, identifying markers of
tumour progression. The process of ovarian carcinogenesis should
also be revealed using this system.
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